EP3853317A4 - Artificial tear, contact lens and drug vehicle compositions and methods of use thereof - Google Patents

Artificial tear, contact lens and drug vehicle compositions and methods of use thereof Download PDF

Info

Publication number
EP3853317A4
EP3853317A4 EP19863887.6A EP19863887A EP3853317A4 EP 3853317 A4 EP3853317 A4 EP 3853317A4 EP 19863887 A EP19863887 A EP 19863887A EP 3853317 A4 EP3853317 A4 EP 3853317A4
Authority
EP
European Patent Office
Prior art keywords
methods
contact lens
artificial tear
drug vehicle
vehicle compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19863887.6A
Other languages
German (de)
French (fr)
Other versions
EP3853317A2 (en
Inventor
Gerald Horn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ps Therapy Inc
Original Assignee
Ps Therapy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/137,738 external-priority patent/US20190021990A1/en
Priority claimed from US16/372,625 external-priority patent/US11583496B2/en
Priority claimed from US16/372,582 external-priority patent/US20190224136A1/en
Priority claimed from US16/372,596 external-priority patent/US20190225917A1/en
Priority claimed from US16/412,943 external-priority patent/US20190262290A1/en
Application filed by Ps Therapy Ltd filed Critical Ps Therapy Ltd
Publication of EP3853317A2 publication Critical patent/EP3853317A2/en
Publication of EP3853317A4 publication Critical patent/EP3853317A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19863887.6A 2018-09-21 2019-09-19 Artificial tear, contact lens and drug vehicle compositions and methods of use thereof Pending EP3853317A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US16/137,738 US20190021990A1 (en) 2016-10-12 2018-09-21 Artificial tear compositions and methods of use thereof
US16/372,625 US11583496B2 (en) 2016-10-12 2019-04-02 Drug vehicle compositions and methods of use thereof
US16/372,582 US20190224136A1 (en) 2016-10-12 2019-04-02 Artificial tear compositions and methods of use thereof
US16/372,596 US20190225917A1 (en) 2016-10-12 2019-04-02 Contact lens compositions and methods of use thereof
US16/412,943 US20190262290A1 (en) 2016-10-12 2019-05-15 Drug vehicle compositions and methods of use thereof
PCT/US2019/051825 WO2020061249A2 (en) 2018-09-21 2019-09-19 Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
EP3853317A2 EP3853317A2 (en) 2021-07-28
EP3853317A4 true EP3853317A4 (en) 2022-06-22

Family

ID=69887791

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19863887.6A Pending EP3853317A4 (en) 2018-09-21 2019-09-19 Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Country Status (6)

Country Link
EP (1) EP3853317A4 (en)
JP (1) JP2022511335A (en)
CN (1) CN113227304A (en)
BR (1) BR112021005097A2 (en)
CA (1) CA3112278A1 (en)
WO (1) WO2020061249A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220350163A1 (en) * 2021-04-29 2022-11-03 Coopervision International Limited Ws12-releasing contact lens
CN115671256B (en) * 2021-07-30 2024-04-09 四川大学华西医院 Use of cyclosporin A in combination with diquafosol sodium for the preparation of a medicament for the treatment of dry eye

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140377210A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Artificial tear compositions
US20180098937A1 (en) * 2016-10-12 2018-04-12 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097592A1 (en) * 2000-09-13 2004-05-20 Kenji Morishima Eye drops
JP5525816B2 (en) * 2007-09-14 2014-06-18 ロート製薬株式会社 Ophthalmic composition
CA2784492C (en) * 2009-12-15 2020-06-30 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
US8597629B1 (en) * 2013-06-21 2013-12-03 Premium Ocular Solutions LLC. Artificial tear compositions comprising a combination of nonionic surfactants
EP3470059B1 (en) * 2015-01-26 2020-04-01 Bausch & Lomb Incorporated Ophthalmic suspension composition
JP7324566B2 (en) * 2015-05-28 2023-08-10 ロート製薬株式会社 Aqueous ophthalmic composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140377210A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Artificial tear compositions
US20180098937A1 (en) * 2016-10-12 2018-04-12 Ps Therapies Ltd Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Also Published As

Publication number Publication date
WO2020061249A3 (en) 2020-07-23
CA3112278A1 (en) 2020-03-26
WO2020061249A2 (en) 2020-03-26
EP3853317A2 (en) 2021-07-28
BR112021005097A2 (en) 2021-06-08
JP2022511335A (en) 2022-01-31
CN113227304A (en) 2021-08-06

Similar Documents

Publication Publication Date Title
EP3525885A4 (en) Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
EP3624773A4 (en) Ophthalmic compositions and methods of use
EP3706741A4 (en) Pharmaceutical composition and use thereof
AU2018290633A1 (en) Conjugate of VEGF-Grab protein and drug, and use thereof
EP3500255A4 (en) Ophthalmic pharmaceutical compositions and uses relating thereto
EP3452075A4 (en) Ophthalmic pharmaceutical composition
EP3784268A4 (en) Combinations of osteopontin and 2'-fucosyllactose for use as medicaments
EP3672587A4 (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
EP3685828A4 (en) Ophthalmic pharmaceutical composition, ophthalmic kit, and pharmaceutical application thereof
EP3651747A4 (en) Compositions and methods for the treatment of eye disorders
EP3721890A4 (en) Ophthalmic drug preparation and uses thereof
EP3765095A4 (en) Ophthalmic compositions, and ocular uses thereof, of indigo carmine
EP3744316A4 (en) Ophthalmic pharmaceutical composition, preparation method therefor and application thereof
EP3503873A4 (en) Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
EP3952881A4 (en) Compositions and methods for the treatment of contact lens discomfort
EP3821012A4 (en) Retrotransposon-based delivery vehicle and methods of use thereof
EP3700478A4 (en) Corneal implant systems and methods
EP3654964A4 (en) Composition and methods for the treatment of myopia
EP3672598A4 (en) Ocular pharmaceutical compositions
EP3773654A4 (en) Polypharmaceutical drug compositions and related methods
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
EP3853317A4 (en) Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
EP3589704A4 (en) Coating composition comprised of a hydrophilic crosslinker, a hydrophobic crosslinker and optionally a hydrogel and methods of making and using the same
EP3880690A4 (en) Peptides and pharmaceutical compositions for treating eye diseases
EP3697411A4 (en) Novel pharmaceutical composition and use thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210329

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220524

RIC1 Information provided on ipc code assigned before grant

Ipc: A61L 12/12 20060101ALN20220518BHEP

Ipc: A61K 9/08 20060101ALI20220518BHEP

Ipc: C09K 3/00 20060101AFI20220518BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PS THERAPY, INC.

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230426